Ośrodek Zastosowań Biotechnologicznych Megabolsp. z o.o.

Manufacture of homogenised food preparations and dietetic food

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-04-02
Share capital
1,600,000.00 PLN
Registered address
ul. Franciszkańska 104/112, 91-845 Łódź, Poland

Financials

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2024, 10 days late).

  • 2025not filed
  • 202425/07/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Division · Manufacture of food products2,285 / 4,694
Top 49%
Sector · Manufacturing13,349 / 33,747
Top 40%
Voivodeship · Łódzkie5,388 / 23,393
Top 23%
Country · Poland104,731 / 495,867
Top 21%

Results vs industry

Revenue
This companyUSD 1.35mMedianUSD 483.69kAverageUSD 6.69m
Net profit
This companyUSD 359.13kMedianUSD 12.34kAverageUSD 535.92k
Operating costs
This companyUSD 985.57kMedianUSD 492.39kAverageUSD 5.88m
Assets
This companyUSD 1.53mMedianUSD 421.84kAverageUSD 5.96m

Authorized Representatives

Maciej Jacek Tyrowiczage 54 – President of the Management Board

Manner of representation

Each member of the management board is independently authorised to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
3,200$86,439.7620%
12,800$345,759.0580%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-11-21.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $8,410.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$826
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$780
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,073

Competitors

Name
Puwer Polskasp. z o.o.
Erbafarm Naturalesp. z o.o.
Epicgreensp. z o.o.
Natura Organicasp. z o.o.
Propharmsp. z o.o.
Vianatsp. z o.o.
Vasco Techsp. z o.o.
Symbio PolskaS.A.
BEE & Sonssp. z o.o.
Noblepharma Bissp. z o.o.

FAQ

Last updated: 2026-04-09